Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 17/11/20141 min de leitura
Smith Miller and Patch, Inc. et al.; Withdrawal of Approval of 14 New Drug Applications
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is withdrawing approval of 14 new drug applications (NDAs) from multiple holders of these applications. The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports for the applications.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →